Literature DB >> 14678742

The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review.

Dean E Carter1, H Vasken Aposhian, A Jay Gandolfi.   

Abstract

The aim of this review is to compare the metabolism, chemistry, and biological effects to determine if either of the industrial arsenicals (arsine and gallium arsenide) act like the environmental arsenic oxides (arsenite and arsenate). The metabolism of the arsenic oxides has been extensively investigated in the past 4 years and the differences between the arsenic metabolites in the oxidation states +III versus +V and with one or two methyl groups added have shown increased importance. The arsenic oxide metabolism has been compared with arsine (oxidation state -III) and arsenide (oxidation state between 0 to -III). The different metabolites appear to have different strengths of reaction for binding arsenic (III) to thiol groups, their oxidation-reduction reactions and their forming an arsenic-carbon bond. It is unclear if the differences in parameters such as the presence or absence of methyl metabolites, the rates of AsV reduction compared to the rates of AsIII oxidation, or the competition of phosphate and arsenate for cellular uptake are large enough to change biological effects. The arsine rate of decomposition, products of metabolism, target organ of toxic action, and protein binding appeared to support an oxidized arsenic metabolite. This arsine metabolite was very different from anything made by the arsenic oxides. The gallium arsenide had a lower solubility than any other arsenic compound and it had a disproportionate intensity of lung damage to suggest that the GaAs had a site of contact interaction and that oxidation reactions were important in its toxicity. The urinary metabolites after GaAs exposure were the same as excreted by arsenic oxides but the chemical compounds responsible for the toxic effects of GaAs are different from the arsenic oxides. The review concludes that there is insufficient evidence to equate the different arsenic compounds. There are several differences in the toxicity of the arsenic compounds that will require substantial research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678742     DOI: 10.1016/j.taap.2003.07.009

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  34 in total

1.  Arsenic, stem cells, and the developmental basis of adult cancer.

Authors:  Erik J Tokar; Wei Qu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2010-11-11       Impact factor: 4.849

Review 2.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

3.  Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice.

Authors:  Nicole V Soucy; Debra Mayka; Linda R Klei; Antonia A Nemec; John A Bauer; Aaron Barchowsky
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

Review 4.  Biological and environmental hazards associated with exposure to chemical warfare agents: arsenicals.

Authors:  Changzhao Li; Ritesh K Srivastava; Mohammad Athar
Journal:  Ann N Y Acad Sci       Date:  2016-09-16       Impact factor: 5.691

Review 5.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

6.  Renal function is associated with indicators of arsenic methylation capacity in Bangladeshi adults.

Authors:  Brandilyn A Peters; Megan N Hall; Xinhua Liu; Vesna Slavkovich; Vesna Ilievski; Shafiul Alam; Abu B Siddique; Tariqul Islam; Joseph H Graziano; Mary V Gamble
Journal:  Environ Res       Date:  2015-10-19       Impact factor: 6.498

7.  Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells.

Authors:  Qian Li; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-28       Impact factor: 4.219

8.  Polyamine-stimulation of arsenic-transformed keratinocytes.

Authors:  Eric T Alexander; Kelsey Mariner; Yelizaveta Borodyanskaya; Allyson Minton; Susan K Gilmour
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

9.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

Review 10.  Medical applications and toxicities of gallium compounds.

Authors:  Christopher R Chitambar
Journal:  Int J Environ Res Public Health       Date:  2010-05-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.